Transgene SA (EURONEXT:TNG) - Share price


Stock Report

Transgene SA TNG

Last Price
-

Day Change
-|-%

As of -
- | EUR
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap167.40Mil
52-Wk Range-
Yield %-
ISINFR0005175080
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201620172018
More ...
Income Statement
Revenue2.352.101.34
Operating Income-22.39-28.017.38
Net Income-25.21-32.278.03
Basic EPS-0.44-0.510.13
Avg. Diluted Shares Outstanding586464
Balance Sheet
Current Assets74.0658.7429.75
Non Current Assets48.9042.1478.79
Total Assets122.95100.87108.54
Current Liabilities19.9216.8719.54
Total Liabilities76.4572.7871.84
Total Equity46.5028.0936.70
Cash Flow
Operating Cash Flow-33.59-35.37-28.38
Capital Expenditure-0.05-0.46-1.40
Free Cash Flow-33.63-35.83-29.79

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Transgene SA is a biotechnology company. The company is engaged in discovering, developing and manufacturing targeted immunotherapies for the treatment of oncology and infectious diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

146
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)-3.05
EPS Growth (3 year avg)-
Operating Margin % TTM552.73
Net Margin % TTM601.20
ROE TTM24.78
Debt/Equity1.31
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.